Susceptibility of human pancreatic β cells for cytomegalovirus infection and the effects on cellular immunogenicity

Pancreas

Volumn 41, Issue 1, 2012, Pages 39-49

  Smelt, Maaike J ^a   Faas, Marijke M ^a   De Haan, Bart J ^a   Draijer, Christina ^a   Hugenholtz, Greg C G ^a   De Haan, Aalzen ^a   Engelse, Marten A ^b   De Koning, Eelco J P ^b   De Vos, Paul ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

A cells; cytomegalovirus; immune cell activation; immunogenicity

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCYTE CHEMOTACTIC PROTEIN 1; THYMIDINE; VIRUS PROTEIN;

ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFECTION SENSITIVITY; INSULINOMA; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; VIRUS ATTACHMENT; VIRUS GENE; VIRUS REPLICATION; VIRUS STRAIN;

ANTIGENS, CD58; CADAVER; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FIBROBLASTS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; INSULIN-SECRETING CELLS; INSULINOMA; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES, MONONUCLEAR; RECEPTORS, CHEMOKINE; SPECIES SPECIFICITY; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84655169665     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821fc90c     Document Type: Article

References (69)

1. Hillebrands JL, Van Der Werf N, Klatter FA, et al. Role of peritoneal macrophages in cytomegalovirus-induced acceleration of autoimmune diabetes in BB-rats. Clin Dev Immunol. 2003;10:133-139. (Pubitemid 38089404)
2. Pak CY, Eun HM, McArthur RG, et al. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet. 1988;2:1-4.
3. Jenson AB, Rosenberg HS, Notkins AL. Pancreatic islet-cell damage in children with fatal viral infections. Lancet. 1980;2:354-358.
4. Ward KP, Galloway WH, Auchterlonie IA. Congenital cytomegalovirus infection and diabetes. Lancet. 1979;1:497.
5. Tirabassi RS, Guberski DL, Blankenhorn EP, et al. Infectionwith viruses from several families triggers autoimmune diabetes in LEW.*1WR1 rats: prevention of diabetes by maternal immunization. Diabetes. 2010;59:110-118.
6. Leung Ki EL, Venetz JP, Meylan P, et al. Cytomegalovirus infection and new-onset post-transplant diabetes mellitus. Clin Transplant.2008;22:245-249. (Pubitemid 351420021)
7. Hjelmesaeth J, Sagedal S, Hartmann A, et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia. 2004;47:1550-1556. (Pubitemid 39371637)
8. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation. 1997;64:979-983. (Pubitemid 27446762)
9. Eckhard M, Martin I, Eich T, et al. Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function. Transplant Proc. 2002;34:1922-1924.
10. CITR Research Group. 2009 Annual Report of the CITR. Combined Islet Transplantation Registry. Available at: https://web.emmes.com/ study/isl/reports/reports.htm.
11. Smelt MJ, de Haan BJ, Faas MM, et al. Effects of acute cytomegalovirus infection on rat islet allograft survival. Cell Transplant. 2011;20:1271-1283.
12. Mocarski ES Jr, Shenk T, Pass RF. Fields Virology. Vol. II. 5th ed.Philadelphia, PA: Lippincott-Raven; 2007:2702-2772.
13. Hendrix RM, Wagenaar M, Slobbe RL, et al. Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol. 1997;50:59-63. (Pubitemid 27060208)
14. Isaacson MK, Feire AL, Compton T. Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J Virol. 2007;81:6241-6247. (Pubitemid 46878030)
15. Feire AL, Koss H, Compton T. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci U S A. 2004;101: 15470-15475. (Pubitemid 39441565)
16. 3is a coreceptor for human cytomegalovirus. Nat Med. 2005;11:515-521. (Pubitemid 40685974)
17. Huotari MA, Palgi J, Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of β cellulin as a novel β-cell mitogen. Endocrinology. 1998;139:1494-1499. (Pubitemid 28513801)
18. Browne EP, Wing B, Coleman D, et al. Altered cellular mRNA levels in human cytomegalovirusYinfected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol. 2001;75:12319-12330. (Pubitemid 33115904)
19. Juckem LK, Boehme KW, Feire AL, et al. Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J Immunol. 2008;180:4965-4977.
20. Craigen JL, Grundy JE. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation. 1996;62:1102-1108. (Pubitemid 26376660)
21. Vossen MT, Westerhout EM, Soderberg-Naucler C, et al. Viral immune evasion: a masterpiece of evolution. Immunogenetics. 2002;54:527-542. (Pubitemid 35435511)
22. Smelt MJ, Faas MM, de Haan BJ, et al. Rat pancreatic β cells and cytomegalovirus infection. Pancreas. 2010;39:47-56.
23. Baroni MG, Cavallo MG, Mark M, et al. β-cell gene expression and functional characterisation of the human insulinoma cell line CM. J Endocrinol. 1999;161:59-68. (Pubitemid 29170192)
24. Gragnoli C. The CM cell line derived from liver metastasis of malignant human insulinoma is not a valid β cell model for in vitro studies. J Cell Physiol. 2008;216:569-570. (Pubitemid 351898487)
25. Cavallo MG, Dotta F, Monetini L, et al. β-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native β cells. J Endocrinol. 1996;150:113-120. (Pubitemid 26232641)
26. Cavallo MG, Baroni MG, Toto A, et al. Viral infection induces cytokine release by β islet cells. Immunology. 1992;75:664-668.
27. Monetini L, Cavallo MG, Barone F, et al. T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes. Autoimmunity. 1999;29:171-177. (Pubitemid 29204303)
28. Cha TA, Tom E, Kemble GW, et al. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol. 1996;70:78-83. (Pubitemid 126508771)
29. Murphy E, Yu D, Grimwood J, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A. 2003;100:14976-14981. (Pubitemid 37518002)
30. Ichii H, Pileggi A, Molano RD, et al. Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant. 2005;5:21-30. (Pubitemid 40095124)
31. Smelt MJ, Faas MM, de Haan BJ, et al. Pancreatic β-cell purification by altering FAD and NAD(P)H metabolism. Exp Diabetes Res. 2008;2008:165360.
32. Harmsen MC, Swart PJ, de Bethune MP, et al. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis. 1995;172:380-388.
33. de Haan A, Van De Gun I, Van Dijk E, et al. Activation of alloreactive T cells by allogeneic nonprofessional antigen-presenting cells and interleukin-12 from bystander autologous professional antigen-presenting cells. Transplantation. 2000;69:1637-1644.
34. Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia. 2005;48:1510-1522. (Pubitemid 41175504)
35. Numazaki K, Nagata N, Sato T, et al. Replication of human cytomegalovirus in the cells of the U937 monocytoid cell line. Med Microbiol Immunol. 1992;181:323-331. (Pubitemid 23030440)
36. Saez-Lopez C, Ngambe-Tourere E, Rosenzwajg M, et al. Immediate-early antigen expression and modulation of apoptosis after in vitro infection of polymorphonuclear leukocytes by human cytomegalovirus. Microbes Infect. 2005;7:1139-1149. (Pubitemid 41316687)
37. Gerna G, Percivalle E, Baldanti F, et al. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol. 2000;74:5629-5638. (Pubitemid 30346597)
38. Minton EJ, Tysoe C, Sinclair JH, et al. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol. 1994;68:4017-4021. (Pubitemid 24177428)
39. + progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood. 1996;88:1277-1283. (Pubitemid 26276802)
40. Michelson S, Rohrlich P, Beisser P, et al. Human cytomegalovirus infection of bone marrow myofibroblasts enhances myeloid progenitor adhesion and elicits viral transmission. Microbes Infect. 2001;3:1005-1013. (Pubitemid 32913699)
41. Verkerk MS, Visseren FL, Paul BK, et al. Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus. Eur J Clin Invest. 003;33:720-725.
42. Hosenpud JD, Chou SW, Wagner CR. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation. 1991;52:896-903.
43. Detrick B, Rhame J, Wang Y, et al. Cytomegalovirus replication in human retinal pigment epithelial cells. Altered expression of viral early proteins. Invest Ophthalmol Vis Sci. 1996;37:814-825. (Pubitemid 26110433)
44. Cinatl J Jr, Margraf S, Vogel JU, et al. Human cytomegalovirus circumvents NF-JB dependence in retinal pigment epithelial cells. J Immunol. 2001;167:1900-1908. (Pubitemid 32747494)
45. Hayashi K, Fujisaki Y. Abnormal glucose metabolism in murine cytomegalovirus (MCMV)Yinfected mice. Microbiol Immunol. 1985;29:429-439. (Pubitemid 15066177)
46. Patterson J, Jesser R, Weinberg A. Distinctive in vitro effects of T-cell growth cytokines on cytomegalovirus-stimulated T-cell responses of HIV-infected HAART recipients. Virology. 2008;378:48-57.
47. Ihm SH, Matsumoto I, Zhang HJ, et al. Effect of short-term culture on functional and stress-related parameters in isolated human islets. Transpl Int. 2009;22:207-216.
48. Ozasa T, Newton MR, Dallman MJ, et al. Cytokine gene expression in pancreatic islet grafts in the rat. Transplantation. 1997;64: 1152-1159. (Pubitemid 27467942)
49. Cardozo AK, Proost P, Gysemans C, et al. IL-1A and IFN-F induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia. 2003;46:255-266. (Pubitemid 36343890)
50. Monti P, Scirpoli M, Maffi P, et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest. 2008;118:1806-1814. (Pubitemid 351632383)
51. Schroppel B, Zhang N, Chen P, et al. Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation. J Am Soc Nephrol. 2005;16:444-451. (Pubitemid 41725140)
52. Gysemans CA, Cardozo AK, Callewaert H, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology. 2005;146:1956-1964.
53. Lund T, Fosby B, Korsgren O, et al. Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transpl Int. 2008;21:669-678. (Pubitemid 351852766)
54. Lewis EC, Weiler M, Tejman-YarDen N, et al. Involvement of graft-derived interleukin-15 in islet allograft rejection in mice. Cytokine. 2006;34:106-113. (Pubitemid 43817558)
55. Berney T, Pileggi A, Molano RD, et al. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Transplantation. 2003;76:1669-1674. (Pubitemid 38032411)
56. Bottazzo GF, Dean BM, McNally JM, et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985;313:353-360. (Pubitemid 15046367)
57. Foulis AK, Farquharson MA, Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987;30:333-343. (Pubitemid 17083703)
58. Prichard MN, Penfold ME, Duke GM, et al. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol. 2001;11:191-200. (Pubitemid 32510202)
59. Iversen AC, Steinkjer B, Nilsen N, et al. A proviral role for CpGin cytomegalovirus infection. J Immunol. 2009;182:5672-5681.
60. Beutler B, Crozat K, Koziol JA, et al. Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model. Curr Opin Immunol. 2005;17:36-43. (Pubitemid 40094011)
61. Tabeta K, Georgel P, Janssen E, et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mousecytomegalovirus infection. Proc Natl Acad Sci U S A. 2004;101:3516-3521. (Pubitemid 38338227)
62. Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol. 2002;25(suppl 2):S123-S136. (Pubitemid 35287198)
63. Simon CO, Seckert CK, Dreis D, et al. Role for tumor necrosis factor α in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol. 2005;79:326-340. (Pubitemid 39648387)
64. Ebnet K, Brown KD, Siebenlist UK, et al. Borrelia burgdorferi activates nuclear factor-JB and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol. 1997;158:3285-3292. (Pubitemid 127484045)
65. Sedmak DD, Guglielmo AM, Knight DA, et al. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol. 1994;144:683-692. (Pubitemid 24172057)
66. Cheeran MC, Jiang Z, Hu S, et al. Cytomegalovirus infection and interferon-F modulate major histocompatibility complex class I expression on neural stem cells. J Neurovirol. 2008;20:1-11.
67. Mathiesen T, Collins VP, Ohlsson E, et al. Induction of MHCclass I antigen expression following infection of a human esthesioneuroblastoma cell line with cytomegalovirus and human immunodeficiency virus. Acta Virol. 1992;36:551-556.
68. Ibrahim L, Dominguez M, Yacoub M. Primary human adult lungepithelial cells in vitro: response to interferon-gamma and cytomegalovirus. Immunology. 1993;79:119-124. (Pubitemid 23151203)
69. Van Dorp WT, Van Wieringen PA, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation. 1993;55:1367-1371. (Pubitemid 23183253)